Malignant catatonia in a patient with bipolar disorder, B 12 deficiency, and neuroleptic malignant syndrome: One cause or three?

Journal of Psychiatric Practice

Volumn 15, Issue 5, 2009, Pages 415-422

  Lewis, Lee ^a   Kahn, David A ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Bipolar disorder; Catatonia; Malignant catatonia; Mood disorders; Neuroleptic malignant syndrome; Psychosis; Vitamin B 12 deficiency

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CYANOCOBALAMIN; LORAZEPAM; OLANZAPINE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ADULT; BIPOLAR DISORDER; CASE REPORT; CATATONIA; CYANOCOBALAMIN DEFICIENCY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTROCONVULSIVE THERAPY; EXTRAPYRAMIDAL SYMPTOM; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; NEUROLEPTIC MALIGNANT SYNDROME; NOTE; PARANOID PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

BIPOLAR DISORDER; CATATONIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA, PARANOID; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

EID: 70349738016     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000361282.95962.9f     Document Type: Note

References (50)

1. Kahlbaum KL. Catatonia. Levi Y, Pridon T, trans. Baltimore: Johns Hopkins University Press; 1973.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, second edition. Washington, DC; American Psychiatric Association; 1968.
3. Bush G, Fink M, Petrides G, et al. Catatonia, I: Rating scale and standardized examination. Acta Psychiatr Scand 1996;93:129-136
4. Abrams R, Taylor MA. Catatonia: A prospective clinical study. Arch Gen Psychiatry 1976;33:579-581
5. Abrams R, Taylor MA, Storulow KAC. Catatonia and mania: Patterns of cerebral dysfunction. Biol Psychiatry 1979;14:111-117 (Pubitemid 9133850)
6. Taylor MA, Abrams R. Catatonia: Prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 1977;34:1223-1225 (Pubitemid 8216735)
7. Detweiler MB, Mehra A, Rowell T, et al. Delerious mania and malignant catatonia: A report of 3 cases and review. Psychiatr Q 2009:80:23-40.
8. Morrison JR. Catatonia: Retarded and excited types. Arch Gen Psychiatry 1973;28:39-41.
9. Morrison JR. Karl Kauhlbaum and catatonia. Compr Psychiatry 1974;15:315-316
10. Morrison JR. Catatonia: Diagnosis and treatment. Hosp Community Psychiatry 1975;26:91-94
11. Gelenburg AJ. The catatonic syndrome. Lancet 1976;1 (7973): 339-341
12. Fink M, Taylor MA. Catatonia: A clinician's guide to diagnosis and treatment. Cambridge, UK: Cambridge University Press; 2003.
13. Kosten TR, Kleber ND. Rapid death during cocaine abuse: A variant of the neuroleptic malignant syndrome? Am J Drug Alcohol Abuse 1988;14:335-346
14. McCarron MM, Schulze BW, Thompson GA, et al. Acute phencyclidine intoxication: Clinical patterns, complication, and treatment. Ann Emerg Med 1981;10:290-297
15. Kanemoto K, Miyamoto T, Abe R. Ictal catatonia as a manifestation of a de novo absence status epilepticus following benzodiazepine withdrawal. Seizure 1999;8:364-366 (Pubitemid 29469329)
16. Ezrin-Waters C, Miller P, Seeman P. Catalepsy induced by morphine or haloperidol: Effects of apomorphine and anticholinergic drugs. Can J Physiol Pharmacol 1976;54: 516-519
17. Primavera A, Fonti A, Novello P, et al. Epileptic seizures in patients with acute catatonic syndrome. J Neurol Neurosurg Psychiatry 1994;54:1419-1422 (Pubitemid 24342314)
18. Taylor MA, Fink M. Catatonia in psychiatric classification: A home of its own. Am J Psychiatry 2003;160: 1233-1241 (Pubitemid 41070938)
19. Kraepelin E. Dementia praecox and paraphrenia (1919). Barclay RM, trans; Robertson GM, ed. New York: Robert E Krieger; 1971.
20. Kraepelin E. Manic-depressive insanity and paranoia (1921). Barclay RM, trans. Salem, NH: Ayer; 1976.
21. Chandrasena R. Catatonic schizophrenia: An international comparative study. Can J Psychiatry 1986;31:249-252 (Pubitemid 16118592)
22. Dhossche D, Bouman NH. Catatonia in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997;36: 870-871
23. Kakooza-Mwesige A, Wachtel LE, Dhossche DM. Catatonia in autism: Implications across the life span. Euro Child and Adol Psych. 2008:17:327-335
24. Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord 1993;29:255-261
25. Bell LV. On a form of disease resembling some advanced stages of mania and fever. Am J Insanity 1849;6:97-127.
26. Carroll BT, Taylor BE. The nondichotomy between lethal catatonia and neuroleptic malignant syndrome. J Clin Psychopharmacology 1997;17:235-236
27. Carroll BT, Graham KT, Thalassinos AJ. A common pathogenesis of the serotonin syndrome, catatonia, and neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci 2001;13:150.
28. Fink M. Neuroleptic malignant syndrome: One entity or two? Biol Psychiatry 1996;39:1-4.
29. Chandler JD. Psychogenic catatonia with elevated cratine kinasse and autonomic hyperactivity. Can J Psychiatry 1991;36:530-532
30. Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychiatry Clin Neurosci 1994;6:1-13.
31. Fricchione G, Mann SC, Caroff SN. Catatonia, lethal catatonia and neuroleptic malignant syndrome. Psychiatr Annals 2000;30:347-355
32. Gibson RC, Walcott G. Benzodiazepines for catatonia in people with schizophrenia and other serious mental illnesses. Cochrane Database Syst Rev 2008(4):CD006570. (Pubitemid 351805717)
33. Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: A review. Psychiatric Serv 1998;49: 1163-1172
34. Worrel J, Marken R, Beckman S, et al. Atypical antipsychotic agents: A critical review. Am J Health-Syst Pharm 2000;57:238-255 (Pubitemid 30112339)
35. 12 deficiency and psychiatry: A largely unnoticed but devastating relationship? Med Hypotheses 1991;34:131-140
36. 12 deficiency? J Am Geriatr Soc 1988;36: 1105-1112
37. 12 deficiency? Psychosomatics 1998;39:456-460
38. Wells AJ, Sommi RW, Crisman ML. Neuroleptic rechallenge after neuroleptic malignant syndrome: Case report and literature review. Drug Intell Clin Pharm 1988;22: 475-480 (Pubitemid 18130232)
39. Guzofski S, Peralta R. Neuroleptic malignant syndrome, with attention to its occurrence with atypical antipsychotic medication: A review. Jefferson Journal of Psychiatry 2006;20:53-61.
40. Rosebush PI, Stewart TD, Gelenburg AJ. Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psychiatry 1989;50:295-298 (Pubitemid 19212698)
41. Trutia A. Bledwoski J, Pandurangi A, case presentation, Kahn DA, commentary. Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome. J Psychiatr Pract 2008;14: 398-402
42. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull epub ahead of print July 8, 2009.
43. Zucker DK, Livingston RL, Nakra R, et al. B12 deficiency and psychiatric disorders: Case report and literature review. Biol Psychiatry 1981;2:197-205 (Pubitemid 11186522)
44. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000.
45. 12 deficiency, except where I give other specific citations.
46. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis N Engl J Med 1988;318: 1720-1728
47. Kvittingen EA, Spangen S, Lindemans J, et al. Methionine synthase deficiency without megaloblastic anemia. Eur J Pediatr 1997;56:925-930 (Pubitemid 28006310)
48. Kumar, S.Vitamin B12 deficiency presenting with an acute reversible extrapyramidal syndrome. Neurol India 2004; 52:507-509 (Pubitemid 40110579)
49. Poddar R, Paul S. Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J Neurochem 2009;110: 1095-1106
50. Selhub J. Public health significance of elevated homocysteine. Food Nutr Bull 2008 (2 suppl):S116-25.